Investing News
Market News
Technology
BioNTech SE and Pfizer Inc. announced initial data from their ongoing German Phase ½ COVID-19 Vaccine Study
BioNTech SE (NASDAQ: BNTX) and Pfizer Inc. (NYSE: PFE) announced initial data from their ongoing German Phase 1/2, open-label, non-randomized, non-placebo-controlled, dose-escalation trial, that is part of the global...